New hope for esophageal cancer patients who failed immunotherapy
Disease control
Not yet recruiting
This study tests a combination of two drugs, SHR-1701 and liposomal irinotecan, in 33 adults with esophageal squamous cell carcinoma who have already received immunotherapy. The goal is to see if the combo can shrink tumors or stop them from growing. Participants will receive the…
Phase: PHASE2 • Sponsor: Zhigang Li • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC